DK0744947T3 - Metronidazolpræparater med modificeret afgivelse og fremgangsmåde til deres fremstilling og anvendelse - Google Patents

Metronidazolpræparater med modificeret afgivelse og fremgangsmåde til deres fremstilling og anvendelse

Info

Publication number: DK0744947T3
Authority: DK; Denmark
Prior art keywords: metronidazole; aqueous; methods; aqueous soluble; compositions
Prior art date: 1994-01-27

Application number

DK95907963T

Other languages

English (en)

Inventor

Subhash Desai

Alan Mark Mancini

Steven Charles Schumann

Original Assignee

Searle & Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-01-27

Filing date

1995-01-04

Publication date

2002-07-29

1995-01-04 Application filed by Searle & Co filed Critical Searle & Co

2002-07-29 Application granted granted Critical

2002-07-29 Publication of DK0744947T3 publication Critical patent/DK0744947T3/da

Links

VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 title abstract 8
229960000282 metronidazole Drugs 0.000 title abstract 8
238000000034 method Methods 0.000 title abstract 3
238000002360 preparation method Methods 0.000 title 2
239000003085 diluting agent Substances 0.000 abstract 4
239000000203 mixture Substances 0.000 abstract 3
239000008194 pharmaceutical composition Substances 0.000 abstract 3
239000008187 granular material Substances 0.000 abstract 2
229920002845 Poly(methacrylic acid) Polymers 0.000 abstract 1
229920001577 copolymer Polymers 0.000 abstract 1
239000012729 immediate-release (IR) formulation Substances 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
239000000314 lubricant Substances 0.000 abstract 1
230000000813 microbial effect Effects 0.000 abstract 1
239000008024 pharmaceutical diluent Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

DK95907963T 1994-01-27 1995-01-04 Metronidazolpræparater med modificeret afgivelse og fremgangsmåde til deres fremstilling og anvendelse DK0744947T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/187,568 US6103262A (en)	1994-01-27	1994-01-27	Modified-release metronidazole compositions and methods for making and using same
PCT/US1995/000005 WO1995020383A1 (en)	1994-01-27	1995-01-04	Modified-release metronidazole compositions and methods for making and using same

Publications (1)

Publication Number	Publication Date
DK0744947T3 true DK0744947T3 (da)	2002-07-29

Family

ID=22689500

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK95907963T DK0744947T3 (da)	1994-01-27	1995-01-04	Metronidazolpræparater med modificeret afgivelse og fremgangsmåde til deres fremstilling og anvendelse

Country Status (16)

Country	Link
US (2)	US6103262A (da)
EP (1)	EP0744947B1 (da)
JP (1)	JPH09508381A (da)
KR (1)	KR100368769B1 (da)
CN (1)	CN1095665C (da)
AT (1)	ATE216236T1 (da)
AU (1)	AU682248B2 (da)
BR (1)	BR9506662A (da)
CA (1)	CA2181985C (da)
DE (1)	DE69526434T2 (da)
DK (1)	DK0744947T3 (da)
ES (1)	ES2174930T3 (da)
MX (1)	MX9602951A (da)
NZ (1)	NZ279368A (da)
PT (1)	PT744947E (da)
WO (1)	WO1995020383A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU8588898A (en)	1997-07-28	1999-02-16	Mary L. Redmond	Composition and process for the treatment of epidermal traumas such as decubitusulcers
US6322819B1 (en) *	1998-10-21	2001-11-27	Shire Laboratories, Inc.	Oral pulsed dose drug delivery system
DE19850445A1 (de) *	1998-11-02	2000-05-04	Falk Pharma Gmbh	Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen
ECSP003851A (es) *	1999-12-22	2002-05-23	Pharmacia Corp	Composicon de liberacion doble de un inhibidor ciclooxigenasa-2
US6423707B1 (en)	2000-08-28	2002-07-23	California Pacific Medical Center	Nitroimidazole ester analogues and therapeutic applications
US8846100B2 (en) *	2006-05-12	2014-09-30	Shire Llc	Controlled dose drug delivery system
WO2012075015A2 (en)	2010-11-29	2012-06-07	Dr. Reddy's Laboratories Ltd.	Oral metronidazole pharmaceutical compositions
EP2806861A1 (en) *	2012-01-23	2014-12-03	Ranbaxy Laboratories Limited	In-situ multilayered tablet technology
JP6487534B2 (ja)	2014-09-05	2019-03-20	シンビオミックスセラピューティクス、エルエルシー	細菌性膣炎の治療に使用するためのセクニダゾール
US11253501B2 (en)	2015-06-01	2022-02-22	Lupin Inc.	Secnidazole formulations and use in treating bacterial vaginosis
US11547675B2 (en) *	2015-08-10	2023-01-10	Purdue Research Foundation	Methods and systems for depositing active ingredients on substrates
GR1008992B (el)	2015-12-17	2017-03-23	Verisfield (Uk) Ltd, Υποκαταστημα Ελλαδας, Εμπορια Φαρμακων	Φαρμακευτικη συνθεση σε μορφη κοκκιων για χορηγηση απο το στομα που περιεχει μετρονιδαζολη ή παραγωγα αυτης και εναν παραγοντα καλυψης της γευσης
CN112007002B (zh) *	2020-08-05	2022-08-12	河北君临药业有限公司	一种质量稳定的甲硝唑片剂组合物及其制备方法
US12280037B2 (en)	2020-09-22	2025-04-22	Evofem Biosciences, Inc.	Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof
US11826477B1 (en) *	2022-06-17	2023-11-28	Imam Abdulrahman Bin Faisal University	Metal organic framework/porous silicate and/or aluminosilicate nanocarrier for blastocystosis treatment

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2944061A (en) *	1957-09-20	1960-07-05		Acyl derivatives and process
FI63335B (fi) *	1979-02-02	1983-02-28	Orion Yhtymae Oy	Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne
JPS6056122B2 (ja) *	1980-05-21	1985-12-09	塩野義製薬株式会社	徐放性製剤
GB8707416D0 (en) *	1987-03-27	1987-04-29	Wellcome Found	Pharmaceutical formulations
US4927639A (en) *	1989-02-02	1990-05-22	Warner-Lambert Company	Modified release gemfibrozil composition
DE4125048A1 (de) *	1991-07-29	1993-02-04	Peggy Albrecht	Arzneimittel mit verzoegerter freisetzung zur behandlung von periodontitis
CA2093282C (en) *	1992-05-04	1999-01-12	Tibor Sipos	Intraoral medicament-releasing device

1994
- 1994-01-27 US US08/187,568 patent/US6103262A/en not_active Expired - Fee Related
1995
- 1995-01-04 CA CA002181985A patent/CA2181985C/en not_active Expired - Fee Related
- 1995-01-04 WO PCT/US1995/000005 patent/WO1995020383A1/en not_active Ceased
- 1995-01-04 KR KR1019960703863A patent/KR100368769B1/ko not_active Expired - Fee Related
- 1995-01-04 NZ NZ279368A patent/NZ279368A/en unknown
- 1995-01-04 DK DK95907963T patent/DK0744947T3/da active
- 1995-01-04 BR BR9506662A patent/BR9506662A/pt not_active IP Right Cessation
- 1995-01-04 JP JP7520048A patent/JPH09508381A/ja not_active Ceased
- 1995-01-04 MX MX9602951A patent/MX9602951A/es not_active IP Right Cessation
- 1995-01-04 ES ES95907963T patent/ES2174930T3/es not_active Expired - Lifetime
- 1995-01-04 DE DE69526434T patent/DE69526434T2/de not_active Expired - Fee Related
- 1995-01-04 CN CN95191364A patent/CN1095665C/zh not_active Expired - Fee Related
- 1995-01-04 PT PT95907963T patent/PT744947E/pt unknown
- 1995-01-04 AT AT95907963T patent/ATE216236T1/de not_active IP Right Cessation
- 1995-01-04 EP EP95907963A patent/EP0744947B1/en not_active Expired - Lifetime
- 1995-01-04 AU AU15967/95A patent/AU682248B2/en not_active Ceased
- 1995-05-19 US US08/445,309 patent/US5618559A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
ATE216236T1 (de)	2002-05-15
DE69526434T2 (de)	2002-10-31
CN1095665C (zh)	2002-12-11
CN1139382A (zh)	1997-01-01
AU1596795A (en)	1995-08-15
NZ279368A (en)	1998-04-27
WO1995020383A1 (en)	1995-08-03
MX9602951A (es)	1997-06-28
JPH09508381A (ja)	1997-08-26
EP0744947A1 (en)	1996-12-04
ES2174930T3 (es)	2002-11-16
US5618559A (en)	1997-04-08
CA2181985C (en)	2000-12-05
US6103262A (en)	2000-08-15
DE69526434D1 (de)	2002-05-23
KR100368769B1 (ko)	2003-05-16
AU682248B2 (en)	1997-09-25
CA2181985A1 (en)	1995-08-03
EP0744947B1 (en)	2002-04-17
PT744947E (pt)	2002-08-30
BR9506662A (pt)	1997-11-18

Publication	Publication Date	Title
PT744947E (pt)	2002-08-30	Composicoes de metronidazole com libertacao modificada e metodos para os fazer e utilizar
IL111647A0 (en)	1995-01-24	Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles, their preparation and pharmaceutical compositions containing them
KR950702409A (ko)	1995-07-29	방출 조절 모르핀 제제(controlled release morphine preparation)
DE69520768D1 (de)	2001-05-31	Pharmazeutische Zubereitungen, die Fluoxetin enthalten
EA200000584A2 (ru)	2000-12-25	Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием
YU69603A (sh)	2006-05-25	Atorvastatin kalcijum u farmaceutskom obliku, njegovoj smeši i farmaceutskoj formulaciji, koja sadrži atorvastatin kalcijum
ZA948670B (en)	1995-07-04	New benzoyl guanidine derivatives,the preparation thereof and their use in pharmaceutical compositions
AU7196096A (en)	1997-06-05	Long-lasting release Nifedipine preparation
SE8204581L (sv)	1983-02-06	Farmaceutiska excipienter
ATE260658T1 (de)	2004-03-15	Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
HUP0401811A2 (hu)	2004-12-28	Javított vízoldékonyságú gyógyszerkészítmény és eljárás az előállítására
NO993027L (no)	1999-08-20	Pyrrolo[3,4-D]pyrimidinonderivater og deres anvendelse som legemidler
MXPA04011914A (es)	2005-03-31	Formulacion farmaceutica de liberacion modificada.
WO2003047529A3 (en)	2003-10-30	Extended release pharmaceutical tablet of metformin
RU95111308A (ru)	1996-12-27	Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция
FR2819720B1 (fr)	2004-03-12	Nouveaux comprimes de fenofibrate
DK0824539T3 (da)	2001-09-24	Dialkyltiacumicin-forbindelser
DK0714387T3 (da)	1998-10-12	Hidtil ukendte bis-naphthalimider til behandling af cancer
PT1534352E (pt)	2008-11-13	Implante para transporte e libertação de agentes farmacologicamente activos e processo para a sua produção
DK1216043T3 (da)	2003-09-01	Formulering med forsinket frigivelse indeholdende alfa-liponsyre-(derivater)
WO2002096870A3 (en)	2003-08-07	Sponge-derived terpenoids and methods of use
WO2001017955A3 (en)	2001-06-21	Hydroxyacetamidobenzenesulphonamide derivatives
ATE327742T1 (de)	2006-06-15	Zweiphasige zusammensetzung mit tramadol
HUE009867T2 (da)	2011-05-30
WO2000007580A3 (en)	2000-05-18	Pharmaceutical compositions against autoimmune diseases